UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020255
Receipt number R000023386
Scientific Title The molecular biologic chracteristic analysis of primary fallopian tube carcinoma.
Date of disclosure of the study information 2016/02/01
Last modified on 2016/12/26 13:48:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The molecular biologic chracteristic analysis of primary fallopian tube carcinoma.

Acronym

The molecular biologic chracteristic analysis of primary fallopian tube carcinoma.

Scientific Title

The molecular biologic chracteristic analysis of primary fallopian tube carcinoma.

Scientific Title:Acronym

The molecular biologic chracteristic analysis of primary fallopian tube carcinoma.

Region

Japan


Condition

Condition

primary fallopian tube carcinoma

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

Molecular biologic characteristic analysis of primary fallopian tube carcinoma.

Basic objectives2

Others

Basic objectives -Others

It is aimed for the application to a diagnosis in examination, the preoperation of the outbreak factor of uterine tube cancer by analyzing the molecular biologic characteristic of primary fallopian tube carcinoma.

Trial characteristics_1

Others

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Clarify the molecular biologic characteristic of primary fallopian tube carcinoma.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <

Age-upper limit

90 years-old >=

Gender

Female

Key inclusion criteria

primary fallopian tube carcinoma
primary peritoneal carcinoma
high grade serous ovarian carcinoma

Key exclusion criteria

There is particularly no it.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hideki Tokunaga

Organization

TOHOKU UNIVERSITY

Division name

Department of Gynecology and Obsterics

Zip code


Address

1-1, Seiryo-machi, Aoba-ku, Sendai

TEL

022-717-7251

Email

tokunagahideki@med.tohoku.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shoko Sakurada

Organization

TOHOKU UNIVERSITY

Division name

Department of Gynecology and Obstetrics

Zip code


Address

1-1, Seiryo-machi, Aoba-ku, Sendai

TEL

022-717-7251

Homepage URL


Email

s.sakurada@med.tohoku.ac.jp


Sponsor or person

Institute

Department of Gynecology and Obstetrics , Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Department of Gynecology and Obstetrics , Tohoku University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2016 Year 02 Month 01 Day

Date of IRB


Anticipated trial start date

2016 Year 02 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We detect copy number variations and BRCA/p53 about a primary fallopian tube carcinoma, a peritoneum cancer, a high atypical degree ovary serosity adenocarcinoma.


Management information

Registered date

2015 Year 12 Month 17 Day

Last modified on

2016 Year 12 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023386


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name